Analysen von Matthew Weston
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 15.08.24 | AstraZeneca Sell | UBS AG | |
| 13.08.24 | AstraZeneca Sell | UBS AG | |
|
Werbung
|
|||
| 26.07.24 | AstraZeneca Sell | UBS AG | |
| 04.06.24 | AstraZeneca Sell | UBS AG | |
| 21.05.24 | AstraZeneca Sell | UBS AG | |
| 15.05.24 | AstraZeneca Sell | UBS AG | |
| 26.04.24 | AstraZeneca Sell | UBS AG | |
| 25.04.24 | AstraZeneca Sell | UBS AG | |
| 05.04.24 | AstraZeneca Sell | UBS AG | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 09.02.24 | AstraZeneca Sell | UBS AG | |
| 08.02.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 16.01.24 | AstraZeneca Sell | UBS AG | |
| 18.10.18 | Roche Underperform | Credit Suisse Group | |
| 27.07.18 | Roche Underperform | Credit Suisse Group | |
| 25.05.18 | Roche Underperform | Credit Suisse Group | |
| 20.04.18 | Novartis Underperform | Credit Suisse Group | |
| 25.01.18 | Novartis Underperform | Credit Suisse Group | |